Vanguard Fiduciary Trust’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
338,345
+2,230
+0.7% +$3.33K ﹤0.01% 3275
2026
Q1
$514K Buy
+336,115
New +$442K ﹤0.01% 3201

Other funds holding BMEA

Vanguard Fiduciary Trust's BMEA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Biomea Fusion (BMEA) stake by 0.66% in Q2 2026, buying an estimated $3.33K and bringing the position to 338,345 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #3275.

Vanguard Fiduciary Trust first reported a position in BMEA in Q1 2026 and has held it in 2 quarters since. The position peaked at $514K in Q1 2026. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Vanguard Fiduciary Trust held 338,345 shares of Biomea Fusion worth $497K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 2,230 Biomea Fusion shares in Q2 2026, an estimated $3.33K.
  • Biomea Fusion made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3275 holding.
  • Vanguard Fiduciary Trust first reported a position in Biomea Fusion in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Biomea Fusion position peaked at $514K in Q1 2026.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.